Literature DB >> 29416133

Rheumatoid arthritis: Long-term mavrilimumab safe and effective.

Sarah Onuora.   

Abstract

Entities:  

Year:  2018        PMID： 29416133     DOI： 10.1038/nrrheum.2018.22

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis.

Authors:  Gerd R Burmester; Iain B McInnes; Joel M Kremer; Pedro Miranda; Jiří Vencovský; Alex Godwood; Marius Albulescu; M Alex Michaels; Xiang Guo; David Close; Michael Weinblatt
Journal:  Arthritis Rheumatol       Date:  2018-03-31       Impact factor: 10.995
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.